Stock Ratings / Health Care / NTRB / forecast

CNXU (56) LAKE (38) AGPU (37) APT (58) ⌘ Pro Terminal →

Nutriband Inc. (NTRB) 12-Month Stock Forecast & Price Target Cone

$6.64 +3.75% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $6.67

Nutriband Inc. (NTRB) carries a Roarable Rating of D- (Sell) with 40/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (40/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $80.7M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $6.67 (+0.48%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (40/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.4% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-8.1% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NTRB)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (40/100 Composite)

🔍 WHY NTRB SCORES 40/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+12/20 pts (30% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (28% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$6.65-6.5% Next Q

Q2 (-2Q)

Grade D$6.22-7.4% Next Q

Q3 (-1Q)

Grade D$5.76+15.3% Next Q

Current

Grade D-$6.64-7.4% Hist 90D α

Trajectory: D (48) → D- (40)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a NTRB Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While NTRB currently carries a cautious 40/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.36) and Max Pain ($6.97) forces dealer call-delta covering toward $9.65.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NTRB• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “NTRB Beats Next Quarter EPS Consensus (Jan 30, 2027) & Holds Above 200D SMA”

YES 40%NO 60%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your NTRB Position Size: $10,000

Shares at $6.64: 1506.0 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $4.76

$7,169

$-2,831 (-28.3%)

12M Consensus BaseTarget $6.10

$9,187

$-813 (-8.1%)

12M Bull Case BreakoutTarget $9.65

$14,533

+$4,533 (+45.3%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 9

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$6	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$9	69%	B
JP MorganUS Large-Cap Research	SELL	$5	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NTRB)

✓Walkthrough of NTRB's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NTRB // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +71.58%📐 HORIZONTAL RANGE

2026-10-30O $6.44H $6.64L $6.20C $6.64VOL 22.2K

RES: $10.87SUP: $2.61SMA50: $6.36SMA200: $4.37

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NTRB Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NTRB Butterfly Map → + Track NTRB →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -4.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NTRB today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NTRB. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NTRB today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NTRB)

Health Care Rank #647 of 1016 ⚔️ CNXU vs NTRB Full Matrix →

1. Head-to-Head Health Care Peer Comparison (NTRB vs. CNXU, LAKE, AGPU, APT)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Nutriband Inc. (NTRB) ranks #647 by composite RQD confidence (40/100, grade D-) and #686 by equity capitalization ($80.7M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with NTRB at 40/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NTRB ACTIVE Nutriband Inc.	D-	40/100	—	27.8%	-35.0%	+3.75%	$80.7M	Benchmark Subject
CNXU Conexeu Sciences Inc.	D+	56/100	—	—	—	-1.74%	$85.8M	/cnxu-vs-ntrb →
LAKE Lakeland Industries Inc.	D-	38/100	—	32.9%	-9.5%	-1.11%	$88.2M	/lake-vs-ntrb →
AGPU Axe Compute Inc.	D-	37/100	—	—	-35.0%	-2.01%	$101.7M	/agpu-vs-ntrb →
APT Alpha Pro Tech Ltd.	D+	58/100	16.2x	38.1%	6.7%	+1.28%	$56.6M	/apt-vs-ntrb →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-01-31 • CIK 0001676047

In its most recent audited fiscal period (FY2025, filed 2026-01-31), Nutriband Inc. (NTRB) reported GAAP revenue of $2.0M (-4.8% vs. FY2024 revenue of $2.1M , and -2.3% cumulative change since FY2023) , GAAP net income of -$8.2M, operating cash flow of -$5.1M, and free cash flow of -$5.1M (-8.9% YoY). On the balance sheet, NTRB closed FY2025 with $7.5M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-01-31	$2.0M	-$8.2M	-$5.1M	-$5.1M	$7.5M	—
FY2024 (FY)	2025-01-31	$2.1M	-$10.5M	-$4.6M	-$4.7M	$7.5M	—
FY2023 (FY)	2024-01-31	$2.1M	-$5.5M	-$3.5M	-$3.5M	—	—

3. NTRB Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NTRB stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Nutriband Inc. (NASDAQ: NTRB) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 40/100 at a spot price of $6.64 (+3.75% 1D, market cap $80.7M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, NTRB ranks #647 in composite RQD confidence.

How does NTRB compare to CNXU and LAKE in the Health Care sector?

Within the Health Care sector (Industrial Specialties), NTRB carries a Roarable D- (40/100 RQD), trailing P/E of N/A, gross margin of 27.8%, and ROIC of -35.0%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D+ grade (56/100 RQD, P/E N/A, ROIC —, cap $85.8M) and LAKE (Lakeland Industries Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -9.5%, cap $88.2M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NTRB?

Per NTRB's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0001676047), Nutriband Inc. generated $2.0M in revenue (-4.8% YoY), -$8.2M in net income, and -$5.1M in free cash flow against $7.5M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NTRB trading relative to its 50-day, 200-day, and 52-week technical levels?

NTRB last traded at $6.64 (+3.75% on volume of 12,620 shares), positioning the stock +4.40% above its 50-day simple moving average ($6.36) and +51.95% above its 200-day simple moving average ($4.37). Across its 52-week range of $2.80 to $9.19, NTRB sits at the 60.1% percentile with a 14-day RSI of 49.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($5.81 to $7.47).

NTRB Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is NTRB's 12-month stock price target?

Nutriband Inc. (NTRB) carries a 12-month consensus base price target of $6.1 (-8.1% from $6.64), with a bull-case target of $9.65 and a bear-case floor of $4.76.

Is NTRB stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates NTRB D- (Sell — SELL) with an RQD Confidence score of 40/100.

Direct Sub-Reports: NTRB RQD Cockpit NTRB 12M Forecast NTRB Earnings & Move NTRB Dividends & DRIP NTRB Insiders & 13F NTRB Whale Options NTRB Profit Sankey NTRB News & Why